SEARCH

SEARCH BY CITATION

Keywords:

  • human;
  • T cells;
  • Treg

PURPOSE AND APPROPRIATE SAMPLE TYPES

  1. Top of page
  2. PURPOSE AND APPROPRIATE SAMPLE TYPES
  3. BACKGROUND
  4. SIMILARITY TO PUBLISHED OMIPs
  5. Acknowledgements
  6. LITERATURE CITED
  7. Supporting Information

The present panel was constructed for the in-depth characterization of human T regulatory cells in both health and disease. The panel works well in both fresh and cryopreserved PBMCs (Table 1). The panel has also been tested on ACK-lysed peripheral blood. No other types of tissues have been tested.2

Table 1. Summary table for application of OMIP-004
PurposeDetermine Treg levels and to provide an in depth characterization of Tregs
SpeciesHuman
Cell typesFresh or cryopreserved PBMCs, ACK-lysed blood
Cross referenceOMIP-001
Table 2. Reagents used for OMIP-004
SpecificityFluorochromeClonePurpose
Dead CellsAqua bluenaViability
CD45QD800HI30Leukocyte gating
CD3APC-Cy7Sk7T cell
CD4V450RPA-T4Helper subset
CD8QD6053B5Suppressor subset
CD25PE-Cy7M-A251Treg gating
CD27QD655CLB-27/1 
CD38PcP-Cy5.5HIT2 
CD39AF488A1Treg suppression
CD45RAPE-TR2H4LDH11LDB9Naïve
CD103PE-Cy5LF61 
CD127AF647hIL-7R-M21Treg gating
CD197AF700150503 
HLA-DrPE-Cy5.5Tu96 
FoxP3PEPCH101Treg marker

BACKGROUND

  1. Top of page
  2. PURPOSE AND APPROPRIATE SAMPLE TYPES
  3. BACKGROUND
  4. SIMILARITY TO PUBLISHED OMIPs
  5. Acknowledgements
  6. LITERATURE CITED
  7. Supporting Information

T regulatory cells (Tregs) are a subset of CD4 T cells, which are capable of suppressing immune responses of other T cells. In the peripheral blood of healthy individuals, these constitute approximately 3–5% of CD4 T cells. Tregs have been identified by a number of differing approaches, involving some, or all, of the following marker expressions: CD25high, Forkhead box protein 3 (FoxP3), and CD127low (1–3). In the current panel, all of these markers were used, as well as additional markers such as CD39 that have been reported to be associated with high suppressive activity among Tregs (4). Antibodies to identify naïve and memory T cells, including CD45RA, CD27, and CD197 (CCR7) have been added to enable classification of Tregs in this manner (5–7). Finally, additional markers for gating (live/dead, CD45, CD3), and for cell activation (CD38, HLA-DR, CD103) were added to this panel (Supporting Information Table 2).

After testing several fluorochromes, R-phycoerythrin was reserved for FoxP3, as this marker was crucial for Treg identification. As this tube is part of a larger T cell panel with recurring markers, such as CD45, CD3, CD4 and CD8, an effort was made to assign these markers to fluorochromes that might not be widely available for other markers. Numerous clones and fluorochrome conjugates of antibodies were tested to optimize staining and minimize compensation (Supporting Information Table 3). FoxP3 is an intracellular antigen and requires the cells to be fixed and permeabilized for staining. This was performed after staining of the surface markers with the other antibodies. The use of the aqua blue live/dead stain still permitted exclusion of dead cells from analysis. Figure 1 illustrates the staining achieved with this panel, and a gating strategy that can be used to identify salient populations (Supporting Information Table 6).

thumbnail image

Figure 1. An example of staining patterns and gating strategies for all fluorescent parameters. PBMC were stained according to the OMIP-004 protocol. (A) Debris and doublets were excluded from analysis. Live mononuclear cells were selected for sequential analysis. T cells were identified by CD3 expression. T cells subsets were identified by expression of CD4 and/or CD8. The CD4 subset was examined for expression of CD25 and Foxp3. (B) Representation of remaining parameters, in CD8+ T cells (left), Treg (center) and CD4+ T cells (right). (C) Expression of CCR7 and CD127 on naive CD8+ (left) and naive CD4+ T cells (right). Naive cells were gated as indicated in Figure 1A, through CD45RA and CD27 bivariate dot plots. Numbers in green next to the dot plots are a reference to the populations reported in online Supporting Information Table 6.

Download figure to PowerPoint

As Tregs are a minor component of CD4 T cells in the peripheral blood, it is necessary to acquire a large number of cells to accurately enumerate the various Treg subsets encountered. It is desirable to acquire a minimum of 50,000 CD4 T cells for analysis, and substantially more if possible. Thus, data files resulting from running this tube generally contained between 300,000 and 1,000,000 events.

SIMILARITY TO PUBLISHED OMIPs

  1. Top of page
  2. PURPOSE AND APPROPRIATE SAMPLE TYPES
  3. BACKGROUND
  4. SIMILARITY TO PUBLISHED OMIPs
  5. Acknowledgements
  6. LITERATURE CITED
  7. Supporting Information

This panel can be used to measure naïve and memory CD4 and CD8 populations in a manner similar to OMIP-001.

Acknowledgements

  1. Top of page
  2. PURPOSE AND APPROPRIATE SAMPLE TYPES
  3. BACKGROUND
  4. SIMILARITY TO PUBLISHED OMIPs
  5. Acknowledgements
  6. LITERATURE CITED
  7. Supporting Information

The authors would like to thank Mario Roederer, Pratip Chattopadhyay, and Steve Perfetto for their assistance in panel development, and Kristin Tarbell for her input regarding Treg markers.

LITERATURE CITED

  1. Top of page
  2. PURPOSE AND APPROPRIATE SAMPLE TYPES
  3. BACKGROUND
  4. SIMILARITY TO PUBLISHED OMIPs
  5. Acknowledgements
  6. LITERATURE CITED
  7. Supporting Information

Supporting Information

  1. Top of page
  2. PURPOSE AND APPROPRIATE SAMPLE TYPES
  3. BACKGROUND
  4. SIMILARITY TO PUBLISHED OMIPs
  5. Acknowledgements
  6. LITERATURE CITED
  7. Supporting Information

Additional Supporting Information may be found in the online version of this article.

FilenameFormatSizeDescription
CYTO_21158_sm_suppinfo1.doc104KSupporting Information
CYTO_21158_sm_suppinfofigs.pdf1095KSupporting Information Figures
CYTO_21158_sm_suppinfo2.doc42KSupporting Information MIFlowCyt Check List
CYTO_21158_sm_suppinfotabs.xlsx55KSupporting Information Tables

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.